BioNTech SE Gains Losses On Financial Assets At Amortised Cost
BioNTech SE (BNTX) reported Gains Losses On Financial Assets At Amortised Cost of EUR 3.10 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:GainsLossesOnFinancialAssetsAtAmortisedCost · last filed 2026-03-10
| Period end | Gains Losses On Financial Assets At Amortised Cost 12 month |
|---|---|
| 2025-12-31 | 3.10M EUR 20-F · filed 2026-03-10 |
| 2024-12-31 | 0.00 EUR 20-F · filed 2026-03-10 |
| 2023-12-31 | 26.70M EUR 20-F · filed 2026-03-10 |